UBS Group’s BlackRock Health Sciences Trust II BMEZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.7M | Sell |
1,169,414
-53,327
| -4% | -$760K | ﹤0.01% | 2015 |
|
|
2025
Q1 | $18.2M | Sell |
1,222,741
-34,392
| -3% | -$512K | ﹤0.01% | 1864 |
|
|
2024
Q4 | $18.1M | Sell |
1,257,133
-155,991
| -11% | -$2.25M | ﹤0.01% | 1848 |
|
|
2024
Q3 | $22.4M | Sell |
1,413,124
-57,839
| -4% | -$916K | ﹤0.01% | 1216 |
|
|
2024
Q2 | $22.6M | Buy |
1,470,963
+107,384
| +8% | +$1.65M | 0.01% | 1159 |
|
|
2024
Q1 | $22.3M | Buy |
1,363,579
+16,804
| +1% | +$275K | 0.01% | 1136 |
|
|
2023
Q4 | $19.7M | Sell |
1,346,775
-601,965
| -31% | -$8.82M | 0.01% | 1103 |
|
|
2023
Q3 | $28.1M | Sell |
1,948,740
-132,247
| -6% | -$1.91M | 0.01% | 864 |
|
|
2023
Q2 | $34.2M | Sell |
2,080,987
-99,757
| -5% | -$1.64M | 0.01% | 765 |
|
|
2023
Q1 | $36.4M | Buy |
2,180,744
+54,442
| +3% | +$910K | 0.01% | 716 |
|
|
2022
Q4 | $32.8M | Sell |
2,126,302
-750,717
| -26% | -$11.6M | 0.01% | 765 |
|
|
2022
Q3 | $43M | Sell |
2,877,019
-387,890
| -12% | -$5.79M | 0.02% | 563 |
|
|
2022
Q2 | $53.6M | Sell |
3,264,909
-499,689
| -13% | -$8.21M | 0.02% | 523 |
|
|
2022
Q1 | $75.5M | Sell |
3,764,598
-304,007
| -7% | -$6.1M | 0.03% | 463 |
|
|
2021
Q4 | $103M | Sell |
4,068,605
-948,682
| -19% | -$24.1M | 0.03% | 413 |
|
|
2021
Q3 | $135M | Buy |
5,017,287
+287,964
| +6% | +$7.77M | 0.04% | 332 |
|
|
2021
Q2 | $137M | Buy |
4,729,323
+637,344
| +16% | +$18.4M | 0.04% | 323 |
|
|
2021
Q1 | $108M | Buy |
4,091,979
+1,825,203
| +81% | +$48M | 0.04% | 368 |
|
|
2020
Q4 | $64.9M | Buy |
2,266,776
+344,095
| +18% | +$9.86M | 0.02% | 503 |
|
|
2020
Q3 | $45.9M | Buy |
1,922,681
+453,793
| +31% | +$10.8M | 0.02% | 540 |
|
|
2020
Q2 | $30.7M | Buy |
1,468,888
+598,283
| +69% | +$12.5M | 0.01% | 654 |
|
|
2020
Q1 | $15.6M | Buy |
+870,605
| New | +$15.6M | 0.01% | 879 |
|